# ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 P&L / Income Statement

- Company: ROIVANT SCIENCES LTD. (ROIV)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q1 FY2026 10-Q, filed 2026-08-06, accession number 0001635088-26-000090
- Page: https://plicit.ai/financials/roiv/fy2026-q1-income-statement
- Chart image: https://plicit.ai/charts/roiv-fy2026-q1-income-statement-sankey.png

## Chart details

Income statement for 2026-04-01 through 2026-06-30. Consolidated revenue, costs and expenses.

- **Revenue**: 1,442,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 367,435,000 US dollars
- **Loss from operations**: negative 365,993,000 US dollars
- **Other income (expense), net (calculated)**: 71,429,000 US dollars
- **Loss before income taxes**: negative 294,564,000 US dollars
- **Income tax (benefit) expense**: negative 3,958,000 US dollars
- **Net loss**: negative 290,606,000 US dollars
- **Undisclosed sources**: 1,442,000 US dollars. The filing reports revenue as one line and discloses no sources of it.
- **Total operating expenses**: 367,827,000 US dollars
- **Gain on litigation settlement**: negative 392,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to ROIVANT SCIENCES LTD.: −$189.84 M; to noncontrolling interests: −$100.77 M.